NCT02557035 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 225
- group Id
- BG001
- value
- 215
- group Id
- BG002
- value
- 440
- units
- Participants
- groups
- description
- Intravenous palonosetron (Aloxi 0.25 mg solution for injection) as an infusion with oral dexamethasone, both given on Day 1, prior to the scheduled start of cisplatin; then dexamethasone from Days 2 through 4. Palonosetron Dexamethasone
- id
- BG000
- title
- I.V. Palonosetron Infusion Plus Dexamethasone
- description
- Intravenous palonosetron (Aloxi 0.25 mg solution for injection) as a bolus with oral dexamethasone, both given on Day 1, prior to the scheduled start of cisplatin; then dexamethasone from Days 2 through 4. Palonosetron Dexamethasone
- id
- BG001
- title
- I.V. Palonosetron Bolus Plus Dexamethasone
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.7
- value
- 59.9
- group Id
- BG001
- spread
- 8.5
- value
- 58.9
- group Id
- BG002
- spread
- 8.6
- value
- 59.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 71
- group Id
- BG002
- value
- 145
- title
- Female
- measurements
- group Id
- BG000
- value
- 151
- group Id
- BG001
- value
- 144
- group Id
- BG002
- value
- 295
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 225
- group Id
- BG001
- value
- 215
- group Id
- BG002
- value
- 440
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 97
- group Id
- BG001
- value
- 109
- group Id
- BG002
- value
- 206
- title
- Grade 0
- measurements
- group Id
- BG000
- value
- 120
- group Id
- BG001
- value
- 100
- group Id
- BG002
- value
- 220
- title
- Grade 1
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 14
- title
- Grade 2
- description
- The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 160
- group Id
- BG001
- value
- 145
- group Id
- BG002
- value
- 305
- title
- None
- measurements
- group Id
- BG000
- value
- 58
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 125
- title
- Occasional
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 10
- title
- Regular
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Alcohol consumption
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 77
- group Id
- BG002
- value
- 158
- title
- non-smoker
- measurements
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 70
- group Id
- BG002
- value
- 151
- title
- Ex-smoker
- measurements
- group Id
- BG000
- value
- 60
- group Id
- BG001
- value
- 66
- group Id
- BG002
- value
- 126
- title
- Regular
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Occasional
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Tobacco consumption
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 225
- group Id
- BG001
- value
- 215
- group Id
- BG002
- value
- 440
- units
- Participants
- groups
- description
- Intravenous palonosetron (Aloxi 0.25 mg solution for injection) as an infusion with oral dexamethasone, both given on Day 1, prior to the scheduled start of cisplatin; then dexamethasone from Days 2 through 4. Palonosetron Dexamethasone
- id
- BG000
- title
- I.V. Palonosetron Infusion Plus Dexamethasone
- description
- Intravenous palonosetron (Aloxi 0.25 mg solution for injection) as a bolus with oral dexamethasone, both given on Day 1, prior to the scheduled start of cisplatin; then dexamethasone from Days 2 through 4. Palonosetron Dexamethasone
- id
- BG001
- title
- I.V. Palonosetron Bolus Plus Dexamethasone
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.7
- value
- 59.9
- group Id
- BG001
- spread
- 8.5
- value
- 58.9
- group Id
- BG002
- spread
- 8.6
- value
- 59.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 71
- group Id
- BG002
- value
- 145
- title
- Female
- measurements
- group Id
- BG000
- value
- 151
- group Id
- BG001
- value
- 144
- group Id
- BG002
- value
- 295
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 225
- group Id
- BG001
- value
- 215
- group Id
- BG002
- value
- 440
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 97
- group Id
- BG001
- value
- 109
- group Id
- BG002
- value
- 206
- title
- Grade 0
- measurements
- group Id
- BG000
- value
- 120
- group Id
- BG001
- value
- 100
- group Id
- BG002
- value
- 220
- title
- Grade 1
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 14
- title
- Grade 2
- description
- The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 160
- group Id
- BG001
- value
- 145
- group Id
- BG002
- value
- 305
- title
- None
- measurements
- group Id
- BG000
- value
- 58
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 125
- title
- Occasional
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 10
- title
- Regular
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Alcohol consumption
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 77
- group Id
- BG002
- value
- 158
- title
- non-smoker
- measurements
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 70
- group Id
- BG002
- value
- 151
- title
- Ex-smoker
- measurements
- group Id
- BG000
- value
- 60
- group Id
- BG001
- value
- 66
- group Id
- BG002
- value
- 126
- title
- Regular
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Occasional
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Tobacco consumption
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle